Model Number D134805 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Cardiac Perforation (2513)
|
Event Date 07/11/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
Initial reporter phone: (b)(6).Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.Investigation is in progress, once completed a supplemental will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
|
Event Description
|
It was reported that a patient underwent an ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter.The catheter was difficult to manipulate and appeared to be above the atrial chamber and thought to be in pericardial space.The physician performed transseptal puncture with difficulty using abbott sheath and transseptal needle.The thermocool® smart touch® sf bi-directional navigation catheter was inserted via the sheath into left atrium, fast anatomical map began, catheter noted to be difficult to manipulate and appeared to be above the atrial chamber, catheter thought to be in pericardial space and severe risk of cardiac tamponade.The catheter was removed, sheath remained in position, trans thoracic ultrasound used to check for tamponade.There was no clinical deterioration under general anesthesia (ga).The catheter was inserted into secondary left atrial sheath and ablation performed with no further issues.At end of procedure, sheath in the pericardial space removed under toe guidance and post reversal of anti-coagulation, observed for 20 mins under ga before reversal with no sign of any tamponade or clinical deterioration whilst in the lab.Though to be associated with transeptal puncture into posterior wall of left atrium prior to catheter insertion.No fault with catheter, associated with transseptal puncture only but reported due to adverse complication when catheter inserted.Multiple attempts have been made to obtain clarification to this complaint.However, no further information has been made available.
|
|
Manufacturer Narrative
|
The investigation was completed on 03-mar-2023.Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device number 30749411l and no internal actions related to the complaint was found during the review.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|